Asia Pacific Congenital Heart Diseases Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
USD
1.39 Billion
USD
2.63 Billion
2025
2033
 예측 기간 |
2026 –2033 |
 시장 규모(기준 연도) |
USD 1.39 Billion |
 시장 규모(예측 연도) |
USD 2.63 Billion |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
아시아 태평양 선천성 심장 질환 시장, 제품 유형별(치료 및 진단), 질병 유형별(무청색증 선천성 심장 질환, 청색증 선천성 심장 질환 및 복합 선천성 심장 기형), 연령대별(선천성 심장 질환 성인, 신생아 및 영아(0~1세), 아동(1~12세) 및 청소년(13~18세)), 최종 사용자별(병원, 소아 심장 센터, 전문 클리닉, 진단 연구소, 연구 및 학술 기관, 가정 간호 환경 및 기타 최종 사용자), 유통 채널별(직접 입찰, 도매 유통업체, 소매 판매, 온라인 판매 및 기타) - 산업 동향 및 2033년까지의 전망
아시아 태평양 선천성 심장 질환 시장 규모
- 아시아 태평양 선천성 심장 질환 시장 규모는 2025년 13억 9천만 달러 였으며, 예측 기간 동안 연평균 8.4%의 성장률을 기록하여 2033년에는 26억 3천만 달러 에 이를 것으로 예상됩니다 .
- 선천성 심장 질환(CHD)은 출생 시부터 존재하는 심장의 구조적 또는 기능적 이상을 말하며, 이는 혈류, 산소 공급 및 전반적인 심혈관 기능에 영향을 미칠 수 있습니다. CHD 관리는 이러한 이상을 발견, 모니터링 및 교정하기 위한 치료(수술적 개입, 카테터 시술 및 약물 치료)와 진단 방법(영상 검사, 심초음파 및 유전자 검사)을 모두 포함합니다.
- 선천성 심장병(CHD)은 청색증이 없는 선천성 심장병, 청색증이 있는 선천성 심장병, 복합 선천성 심장 기형을 포함한 다양한 질환을 포괄하며, 신생아와 영아부터 어린이, 청소년, 성인에 이르기까지 모든 연령대의 환자에게 영향을 미칩니다.
아시아 태평양 선천성 심장 질환 시장 분석
- 아시아 태평양 선천성 심장 질환 시장은 선천성 심장 기형 유병률 증가, 최소 침습 심장 시술 도입 확대, 조기 진단 및 시의적절한 치료의 중요성 인식 제고에 힘입어 꾸준한 성장세를 보이고 있습니다.
- 이 지역의 의료 시스템은 지속적인 현대화를 거듭하고 있으며, 공공 및 민간 투자는 소아과 및 심장 치료 시설 확충, 수술 및 중재 시술 결과 개선, 시술 관련 합병증 감소에 집중되고 있습니다. 청색증이 없는 선천성 심장 질환, 청색증이 있는 선천성 심장 질환, 복합 선천성 심장 기형과 같은 질환들이 널리 알려지면서 효과적인 진단 및 치료 솔루션에 대한 수요가 증가하고 있으며, 이는 지속적인 시장 기회를 창출하고 있습니다.
- 중국은 선진 의료 인프라, 강력한 정부 및 민간 투자, 혁신적인 의료 기술의 높은 도입률, 전문 의료 장비의 광범위한 보급에 힘입어 2025년까지 아시아 태평양 선천성 심장 질환 시장에서 34.11%의 최대 매출 점유율을 기록하며 시장을 주도할 것으로 예상됩니다.
- 인도는 도시화 증가, 의료비 지출 증가, 현대 의료 시설 접근성 향상, 첨단 의료 기술 도입 확대 등에 힘입어 예측 기간 동안 아시아 태평양 선천성 심장 질환 시장에서 가장 빠르게 성장하는 국가가 될 것으로 예상됩니다.
- 치료 부문은 병원과 진료소 전반에 걸쳐 조기 질병 발견 및 지속적인 환자 모니터링에 대한 수요 증가에 힘입어 2025년 시장 매출의 65.95%를 차지하며 가장 큰 비중을 차지할 것으로 예상됩니다.
보고서 범위 및 아시아 태평양 선천성 심장 질환 시장 세분화
|
속성 |
아시아 태평양 선천성 심장 질환 주요 시장 분석 |
|
포함되는 부문 |
|
|
대상 국가 |
아시아태평양
|
|
주요 시장 참여자 |
|
|
시장 기회 |
|
|
부가가치 데이터 정보세트 |
데이터 브리지 마켓 리서치에서 제공하는 시장 보고서는 시장 가치, 성장률, 시장 세분화, 지리적 범위 및 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 체계에 대한 정보를 포함합니다. |
아시아 태평양 선천성 심장 질환 시장 동향
" 영상 판독 및 위험도 분류에 인공지능 통합 "
- 인공지능(AI)을 영상 판독 및 위험도 분류에 통합하는 것은 진단 정확도 향상, 판독 시간 단축, 다양한 의료 환경에서의 임상 의사 결정 지원 개선을 통해 아시아 태평양 선천성 심장 질환 시장에 상당한 성장 기회를 제공합니다.
- 인공지능 기반 도구는 의료 영상, 특히 심장 초음파 및 심장 스캔 영상을 매우 정밀하게 분석하여 임상의가 놓칠 수 있는 미묘한 구조적 이상을 감지하고 선천성 심장 결함(CHD)에 대한 조기 진단 및 위험 평가를 가능하게 합니다.
- 인공지능 기술이 연구에서 점차 검증되고 임상 프로그램에서 시범 운영됨에 따라, 이 지역의 공공 보건 시스템은 더욱 효율적인 업무 흐름, 표준화된 해석, 그리고 자원이 부족한 병원과 농촌 지역으로 첨단 진단 기능을 확대할 수 있는 잠재력으로부터 혜택을 얻을 수 있을 것입니다.
- 이러한 발전은 환자 치료 결과를 개선할 뿐만 아니라 첨단 영상 플랫폼과 예측 모델의 광범위한 도입을 지원하여 아시아 태평양 지역 전반에 걸쳐 진단 및 위험 계층화 솔루션 시장 확대를 촉진합니다.
- 이러한 기술 동향은 진단 서비스 및 위험 평가 솔루션의 확대를 뒷받침하여 아시아 태평양 지역의 선천성 심장 질환 치료 시장 생태계 전반을 강화합니다.
아시아 태평양 선천성 심장 질환 시장 동향
운전사
신생아 선천성 심장 기형 발생률 증가
- 아시아 태평양 지역 신생아의 선천성 심장 기형(CHD) 유병률 증가 및 진단율 향상은 선천성 심장 질환 생태계의 중요한 시장 성장 동력입니다.
- 선천성 심장 기형(CHD)은 가장 흔한 선천적 기형 중 하나이며, 중국, 인도, 인도네시아와 같은 인구가 많은 국가의 지역 보건 연구 및 선별 검사 프로그램에서는 최근 몇 년 동안 상당한 사례 발생률과 발견 범위 확대가 보고되었습니다. 이는 조기 진단, 소아 심장 전문 진료 서비스, 심초음파 시스템 및 중재적 치료 솔루션에 대한 지속적인 수요를 반영합니다.
- 강화된 감시 체계, 신생아 선별 검사 프로그램, 그리고 정부 지원 개입으로 의료 서비스 및 추적 관찰이 필요한 사례가 증가함에 따라 아시아 태평양 지역 전반에 걸쳐 선별 검사 기술, 진단 영상, 소아 심장 수술 및 장기 환자 관리 솔루션에 대한 시장 기회가 확대되었습니다.
- 더 나아가, 의료 인프라에 대한 정부 투자 증가, 개선된 의료비 상환 정책, 그리고 스마트 병원 시스템 도입은 시장 성장을 더욱 가속화하고 있습니다.
- 이러한 추세는 진단된 발병률의 실제 증가와 정책 주도에 따른 사례 확인 및 신생아 건강 등록 개선 모두에 의해 주도되고 있습니다.
- 2025년 7월, 템포(Tempo)는 인도네시아 보건부 장관의 말을 인용하여 매년 약 12,000명의 신생아가 선천성 심장 수술을 필요로 하지만 실제로 수술을 받는 아기는 약 6,000명에 불과하며, 이로 인해 선천성 심장 결함으로 인한 사망자가 연간 약 6,000명에 달한다고 보도했습니다. 이는 심장 질환 치료 자원 확충에 대한 크고 충족되지 않은 임상적 수요를 보여줍니다.
- 아시아 태평양 지역에서 선천성 심장 질환 진단 사례가 증가하고 신생아 선별 검사 및 진단 프로그램이 확대됨에 따라, 이 지역의 건강 부담이 가중되고 있으며, 이는 선천성 심장 질환 진단, 중재 시술 및 치료 서비스에 대한 수요 증가로 이어지고 있습니다.
절제/도전
선천성 심장 질환 치료의 높은 비용
- 선천성 심장 질환(CHD)의 진단, 수술, 기기 치료 및 장기 관리에 드는 높은 비용은 아시아 태평양 지역 시장 성장의 주요 제약 요인으로 작용하고 있습니다.
- 선천성 심장병(CHD) 치료에는 복잡한 개심술, 고난도 중재 시술, 장기간 입원, 평생에 걸친 추적 관리 등이 필요한 경우가 많으며, 이 모든 것이 가족과 공공 의료 시스템에 상당한 재정적 부담을 안겨줍니다.
- 아시아 태평양 지역의 많은 국가에서는 제한적인 보험 적용 범위, 본인 부담 의료비, 그리고 정부 지원 소아 심장 치료에 대한 불균등한 접근성으로 인해 특히 저소득 및 중소득 인구에서 시기적절한 치료를 받는 데 어려움이 있습니다.
- 공공 의료보험 제도가 존재하는 경우에도 자금 부족, 긴 대기 시간, 높은 시술 비용으로 인해 시술 건수가 제한됩니다.
- 이러한 비용 압박은 첨단 기기 및 기술 도입을 제한하고, 치료 과정을 지연시키며, 궁극적으로 해당 지역의 선천성 심장 질환 시장 확장에 구조적 제약으로 작용합니다.
아시아 태평양 선천성 심장 질환 시장 범위
아시아 태평양 선천성 심장 질환 시장은 제품 유형, 질병 유형, 연령대, 최종 사용자 및 유통 채널을 기준으로 다섯 가지 주요 범주로 세분화됩니다.
- 제품 유형별
제품 유형을 기준으로 아시아 태평양 선천성 심장 질환 시장은 진단 및 치료 솔루션으로 구분됩니다. 2026년에는 만성 질환 유병률 증가, 최소 침습 치료에 대한 수요 증가, 심혈관 스텐트, 정형외과 임플란트, 주입 시스템과 같은 맞춤형 치료 장비의 발전으로 치료 부문이 66.05%의 시장 점유율로 시장을 주도할 것으로 예상됩니다.
치료 부문은 만성 질환 및 생활습관병의 증가, 최소 침습 및 카테터 기반 시술의 빠른 도입, 이식형 및 약물 전달 장치의 지속적인 기술 혁신에 힘입어 2026년부터 2033년까지 연평균 8.5%의 가장 빠른 성장률을 보일 것으로 예상됩니다.
- 질병 유형별
아시아 태평양 선천성 심장 질환 시장은 질병 유형에 따라 비청색증성 선천성 심장 질환, 청색증성 선천성 심장 질환, 복합 선천성 심장 결함으로 구분됩니다. 2026년에는 비청색증성 선천성 심장 질환 부문이 유전적 및 환경적 요인으로 인한 높은 유병률, 신생아 선별 검사 및 조기 진단 능력 향상, 심방 중격 결손(ASD) 및 심실 중격 결손(VSD)과 같은 결함에 대한 경피적 카테터 폐쇄술과 같은 최소 침습 치료법의 접근성 확대에 힘입어 51.40%의 시장 점유율로 아시아 태평양 선천성 심장 질환 시장을 주도할 것으로 예상됩니다.
복잡한 선천성 심장 기형 분야는 하이브리드 수술-중재 시술의 발전, 저형성 좌심증후군(HLHS) 및 팔로 사징후와 같은 중증 질환을 가진 신생아의 생존율 증가, 그리고 멜로디 판막 및 스텐트와 같은 특수 기기에 대한 수요 증가에 힘입어 2026년부터 2033년까지 연평균 8.7%의 가장 빠른 성장률을 보일 것으로 예상됩니다.
- 연령대별
아시아 태평양 선천성 심장 질환 시장은 연령대를 기준으로 신생아 및 영아(0~1세), 아동(1~12세), 청소년(13~18세), 그리고 선천성 심장 질환을 가진 성인으로 세분화됩니다. 2026년에는 선천성 심장 질환을 가진 성인 부문이 아시아 태평양 선천성 심장 질환 시장에서 34.46%의 시장 점유율로 가장 큰 비중을 차지할 것으로 예상됩니다. 이는 아동 생존율 향상으로 인한 성인 생존자 인구 증가, 부정맥 및 심부전과 같은 평생 합병증에 대한 인식 제고, 그리고 이식형 제세동기 및 폐고혈압 치료와 같은 전문적인 후속 치료에 대한 수요 증가에 힘입은 결과입니다.
선천성 심장 질환을 가진 성인 환자군은 2026년부터 2033년까지 연평균 8.8%의 가장 빠른 성장률을 보일 것으로 예상됩니다. 이는 소아기 치료 기술의 발전으로 장기 생존자가 증가하고, 부정맥 및 폐고혈압과 같은 이차 질환 발생 위험이 높아져 지속적인 기기 기반 관리가 필요하며, 무선 심박 조율기 및 삼첨판 수술과 같은 첨단 치료법을 제공하는 다학제적 성인 선천성 심장 질환 프로그램에 대한 관심이 높아지는 데 기인합니다.
- 최종 사용자에 의해
최종 사용자를 기준으로 시장은 병원, 소아 심장 센터, 전문 클리닉, 진단 연구소, 연구 및 학술 기관, 가정 간호 환경 및 기타 최종 사용자로 세분화됩니다. 2026년에는 병원 부문이 아시아 태평양 선천성 심장 질환 시장에서 59.22%의 시장 점유율로 주도적인 역할을 할 것으로 예상됩니다. 이는 복잡한 심장 수술 및 카테터 시술을 위한 첨단 인프라, 전문 소아 및 성인 심장 전문의의 집중적인 배치, 그리고 3D 심초음파 및 수술 중 영상과 같은 최첨단 진단 도구에 대한 접근성이 뛰어나기 때문입니다.
소아 심장 센터 부문은 중국과 인도와 같이 발병률이 높은 지역의 전문 시설 급속한 확장, 신생아 및 영유아 치료 인프라 개선을 위한 정부 지원 사업, 하이브리드 심혈관 조영술실 및 태아 심장 프로그램을 갖춘 전문 센터에 대한 수요 급증에 힘입어 2026년부터 2033년까지 연평균 9.1%의 가장 빠른 성장률을 보일 것으로 예상됩니다.
- 유통 채널별
유통 채널을 기준으로 시장은 직접 입찰, 소매 판매, 온라인 판매, 도매 유통업체 및 기타로 세분화됩니다. 2026년에는 직접 입찰 부문이 아시아 태평양 선천성 심장 질환 시장에서 52.83%의 시장 점유율로 주도적인 역할을 할 것으로 예상됩니다. 이는 주요 병원 및 소아 심장 센터의 고가 의료기기(예: 심방중격 폐쇄기 및 스텐트) 대량 구매 선호, 품질 및 가격 투명성을 보장하는 엄격한 규제 표준화, 그리고 중국 및 인도와 같은 국가에서 의료 예산 최적화를 위해 시행되는 정부 주도 중앙 구매 정책에 힘입은 결과입니다.
온라인 판매 부문은 아시아 태평양 지역의 의료 조달 플랫폼의 빠른 디지털화, 개인 병원 및 소규모 병원에서 심장질환 모니터링 도구 및 액세서리와 같은 의료기기에 대한 전자상거래 포털의 도입 증가, 그리고 경쟁력 있는 가격과 빠른 배송을 제공하는 향상된 공급망 효율성에 힘입어 2026년부터 2033년까지 연평균 8.8%의 가장 빠른 성장률을 보일 것으로 예상됩니다.
아시아 태평양 선천성 심장 질환 시장 지역 분석
- 중국은 2025년까지 아시아 태평양 선천성 심장 질환 시장에서 34.11%의 최대 매출 점유율을 기록하며 시장을 주도할 것으로 예상된다.
- 선진 의료 인프라, 강력한 정부 및 민간 투자, 혁신적인 의료 기술의 높은 도입률, 그리고 전문 의료 장비의 광범위한 보급에 힘입어 이러한 현상이 나타나고 있습니다.
- 이 지역은 기술에 대한 관심이 높은 인구, 견고한 규제 체계, 잘 구축된 의료 서비스 시스템 덕분에 병원, 진료소, 진단 센터 전반에 걸쳐 첨단 의료 기기 도입이 용이합니다.
중국 선천성 심장 질환 시장 분석
중국은 거대한 인구 기반으로 인한 높은 선천성 심장병 출생률, '건강한 중국 2030' 계획과 같은 소아 심장 인프라에 대한 정부의 대규모 투자, 그리고 고용량 경피적 및 외과적 시술을 시행하는 첨단 치료 센터의 급속한 확장에 힘입어 2025년 북미 지역에서 가장 큰 매출 점유율을 차지했습니다.
인도 선천성 심장 질환 시장 분석
인도는 급증하는 인구와 증가하는 선천성 심장질환 발병률, 아유슈만 바라트와 같은 대규모 정부 의료 정책으로 소아 심장 수술 접근성이 향상되고, 최소 침습 수술을 위한 하이브리드 심혈관 조영술실을 갖춘 빠르게 성장하는 민간 병원 네트워크 덕분에 예측 기간 동안 상당한 연평균 성장률(CAGR)을 기록하며 성장할 것으로 예상됩니다.
일본 선천성 심장 질환 시장 분석
일본은 선진 의료 시스템을 통해 평생 선천성 심장질환(ACHD) 관리를 지원하고, 높은 소아기 생존율로 인한 고령 생존자 인구 증가, 차세대 판막 및 모니터링 임플란트와 같은 혁신적인 의료기기에 대한 강력한 국민건강보험 적용 범위를 바탕으로 예측 기간 동안 주목할 만한 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다. 로봇 보조 선천성 심장질환 수술 분야의 기술 선도, 도시 지역에서 확대되는 성인 선천성 심장질환 전문 프로그램, 그리고 정부의 적극적인 검진 정책은 아시아 태평양 지역의 선천성 심장질환 시장에서 일본의 꾸준한 시장 확장을 더욱 가속화할 것입니다.
아시아 태평양 선천성 심장 질환 시장 점유율
아시아 태평양 선천성 심장 질환 산업은 주로 다음과 같은 잘 알려진 기업들이 주도하고 있습니다.
- 메드트로닉(미국)
- 에드워즈 라이프사이언스 코퍼레이션(미국)
- 애보트 연구소(미국)
- 보스턴 사이언티픽 코퍼레이션(미국)
- 테루모 주식회사(일본)
- 지멘스 헬스케어(독일)
- 필립스 헬스케어(네덜란드)
- GE 헬스케어(미국)
- 레푸 의료 기술(중국)
- 메릴 라이프 사이언스 주식회사(인도)
- 나랑 메디컬 리미티드(인도)
- 애드바케어 파마(인도)
- 상하이 마이크로포트 과학 주식회사(중국)
- WL Gore & Associates, Inc.(미국)
- B. Braun SE (독일)
- 리바노바 PLC(영국)
- OsCOR Inc.(미국)
- 라이프테크 사이언티픽(중국)
- 아티비온(구 크라이오라이프)(미국)
- 화이자 주식회사(미국)
- 아스트라제네카 PLC (영국)
- 브리스톨-마이어스 스큅(BMS)(미국)
- 선 제약 산업 주식회사(인도)
- 노바티스 AG(스위스)
아시아 태평양 선천성 심장 질환 시장의 최신 동향
- 2025년 6월, 메드트로닉은 세계에서 가장 작은 무선 심박 조율기인 마이크라 AV2와 VR2를 인도에 출시한다고 발표했습니다. 이 제품들은 더 오래 사용할 수 있고, 더 나은 성능을 제공하며, 서맥성 심박동 환자들의 삶을 더욱 편리하게 만들어주도록 설계되었습니다. 마이크라 AV2와 VR2는 메드트로닉 마이크라 무선 심박 조율기 제품군의 최신 혁신 제품입니다. 이 제품들은 전극선이 없고 흉부 절개가 필요하지 않아, 전극선이 있는 기존 심박 조율기에서 발생할 수 있는 감염과 같은 합병증을 예방하는 데 도움이 됩니다.
- 2024년 9월, 메드트로닉(Medtronic plc)은 싱가포르에 동남아시아 최초의 로봇 체험 스튜디오를 개설하여 메드트로닉 고객 경험 센터(MCXC)의 역량을 확장합니다. 이는 의료 생태계 내에서 협력, 교육 및 훈련을 통해 신기술에 대한 접근성을 향상시키고자 하는 메드트로닉의 노력을 보여주는 것입니다.
- 2025년 12월, FDA는 에드워즈 라이프사이언스의 SAPIEN M3 승모판막 치환 시스템을 최초의 경중격 경피적 치료법으로 승인했습니다.
- 2025년 10월, 애보트는 세계 최초의 무선 심장박동기 시스템인 AVEIR 이중 챔버(DR) 시스템을 출시한다고 발표했습니다. 이 초소형 첨단 장치는 최소 침습 시술을 통해 심장 내부에 직접 이식되어 기존 심장박동기처럼 전선(리드)이나 수술 주머니가 필요 없이 심장이 정상적으로 박동하도록 돕습니다.
- 보스턴은 2025년 8월에 새로운 관상동맥 병변 환자를 대상으로 자사의 약물 코팅 풍선(DCB)을 약물 방출 스텐트 또는 풍선 혈관 성형술을 이용한 표준 경피적 관상동맥 중재술(PCI)과 직접 비교하는 AGENT DCB STANCE 임상 시험을 시작했습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC CONGENITAL HEART DISEASE MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END-USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTAL ANALYSSIS
4.2 PORTERS FIVE FORCES ANALYSIS
4.3 COST ANALYSIS BREAKDOWN
4.3.1 INTRODUCTION
4.3.2 CONGENITAL HEART DISEASE COST STRUCTURE OVERVIEW
4.3.2.1 DIAGNOSTIC & IMAGING COST BREAKDOWN
4.3.2.2 SURGICAL TREATMENT COST BREAKDOWN
4.3.2.3 INTERVENTIONAL TREATMENT COST BREAKDOWN
4.3.2.4 HOSPITALIZATION & PROCEDURE COSTS
4.3.2.5 MEDICATION & LONG-TERM CARE COSTS
4.3.3 COST BREAKDOWN BY HOSPITAL TIER
4.3.4 REGIONAL COST VARIATION
4.3.5 MARKET IMPLICATIONS
4.3.6 CONCLUSION
4.4 INDUSTRY INSIGHTS
4.4.1 MICRO AND MACRO ECONOMIC FACTORS
4.4.2 PENETRATION AND GROWTH PROSPECT MAPPING
4.4.3 INTERVIEWS WITH SPECIALISTS
4.4.4 ANALYSIS AND RECOMMENDATION
4.5 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.5.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
4.5.1.1 JOINT VENTURES
4.5.1.2 MERGERS AND ACQUISITIONS
4.5.1.3 LICENSING AND PARTNERSHIP
4.5.1.4 TECHNOLOGY COLLABORATIONS
4.5.1.5 STRATEGIC DIVESTMENTS.
4.5.2 NUMBER OF PRODUCTS IN DEVELOPMENT
4.5.3 STAGE OF DEVELOPMENT
4.5.4 TIMELINES AND MILESTONES
4.5.5 INNOVATION STRATEGIES AND METHODOLOGIES
4.5.6 RISK ASSESSMENT AND MITIGATION
4.5.7 FUTURE OUTLOOK
4.6 NUMBERS OF CONGENITAL HEART DISEASE PATIENT IN EACH COUNTRY
4.7 PATENT ANALYSIS
4.7.1 PATENT QUALITY AND STRENGTH
4.7.2 COUNTRY PATENT LANDSCAPE
4.7.3 IP STRATEGY AND MANAGEMENT
4.7.4 LICENSING AND COLLABORATION
4.8 PREMIUM CLINICAL & COMMERCIAL INSIGHTS:
4.8.1 PATIENT ACCESS
4.8.2 PATIENT DIAGNOSE SITUATION
4.8.3 OPERATION NUMBERS OF CHD PATIENTS
4.8.4 OPERATION NUMBERS OF THE TOP TIER HOSPITAL
4.8.5 TOP SURGEON NAMES
4.8.6 PRODUCT PRICING (AVERAGE SELLING PRICE IN USD)
4.8.6.1 DIAGNOSTIC & IMAGING SYSTEMS
4.8.6.2 SURGICAL DEVICES
4.8.6.3 INTERVENTIONAL DEVICES
4.8.6.4 MEDICATION
4.9 TECHNOLOGY ROADMAP
4.9.1 INTRODUCTION
4.9.2 CURRENT TECHNOLOGY LANDSCAPE (2024–2026)
4.9.2.1 SURGICAL TECHNOLOGIES
4.9.2.2 INTERVENTIONAL DEVICES
4.9.2.3 SUPPORTIVE AND MONITORING TECHNOLOGIES
4.9.2.4 DIGITAL AND DATA-DRIVEN TOOLS
4.9.3 EMERGING TECHNOLOGIES (2026–2030)
4.9.4 FUTURE TECHNOLOGY TRAJECTORY (2030+)
4.9.5 STRATEGIC TAKEAWAYS FOR STAKEHOLDERS
4.9.6 CONCLUSION
4.1 REIMBURSEMENT FRAMEWORK
4.10.1 REIMBURSEMENT STRUCTURES ACROSS ASIA PACIFIC
4.10.2 ROLE OF PUBLIC INSURANCE AND NATIONAL HEALTH POLICIES
4.10.3 PRIVATE INSURANCE AND OUT-OF-POCKET FINANCING
4.10.4 HEALTH TECHNOLOGY ASSESSMENT AND VALUE-BASED REIMBURSEMENT
4.10.5 CHALLENGES IN REIMBURSEMENT FOR CONGENITAL HEART DISEASE CARE
4.10.6 STRATEGIC CONSIDERATIONS FOR MARKET PARTICIPANTS
4.11 OPPORTUNITY MAP ANALYSIS
4.11.1 EXPANSION OF UNIVERSAL HEALTH COVERAGE AND PUBLIC FINANCING
4.11.2 INTEGRATION OF HEALTH TECHNOLOGY ASSESSMENT INTO REIMBURSEMENT
4.11.3 PUBLIC-PRIVATE PARTNERSHIPS TO MITIGATE FINANCIAL BARRIERS
4.11.4 ADDRESSING FRAGMENTATION IN DIGITAL HEALTH REIMBURSEMENT
4.11.5 STRATEGIC ALIGNMENT WITH VALUE-BASED CARE MODELS
4.11.6 STRENGTHENING EQUITABLE ACCESS ACROSS GEOGRAPHIC AND SOCIOECONOMIC LINES
4.11.7 BUILDING CAPACITY FOR REIMBURSEMENT POLICY DEVELOPMENT
4.11.8 CONCLUSION
4.12 SUPPLY CHAIN ECOSYSTEM
4.12.1 PROMINENT COMPANIES
4.12.2 SMALL & MEDIUM SIZE COMPANIES
4.12.3 END USERS
4.13 HEALTHCARE ECONOMY
4.13.1 HEALTHCARE EXPENDITURE
4.13.2 CAPITAL EXPENDITURE
4.13.3 CAPEX TRENDS
4.13.4 CAPEX ALLOCATION
4.13.5 FUNDING SOURCES
4.13.6 INDUSTRY BENCHMARKS
4.13.7 HEALTHCARE EXPENDITURE AS A PROPORTION OF GDP
4.13.8 HEALTHCARE SYSTEM STRUCTURE
4.13.8.1 PUBLIC AND PRIVATE SECTOR COMPOSITION
4.13.8.2 PRIMARY, SECONDARY, AND TERTIARY CARE STRUCTURE
4.13.8.3 REFERRAL AND CARE PATHWAYS
4.13.8.4 REGIONAL DISPARITIES
4.13.8.5 INTEGRATION OF DIGITAL AND TELEHEALTH SERVICES
4.13.8.6 IMPLICATIONS FOR THE CHD MARKET
4.13.9 GOVERNMENT POLICIES
4.13.9.1 HEALTH FINANCING AND REIMBURSEMENT POLICIES
4.13.9.2 REGULATORY AND LICENSING POLICIES
4.13.9.3 NATIONAL HEALTH PROGRAMS AND INITIATIVES
4.13.9.4 TECHNOLOGY ADOPTION AND DIGITAL HEALTH POLICIES
4.13.9.5 IMPLICATIONS FOR THE CHD MARKET
4.13.10 ECONOMIC DEVELOPMENT
4.13.10.1 GDP GROWTH AND HEALTHCARE INVESTMENT
4.13.10.2 INCOME LEVELS AND MARKET SEGMENTATION
4.13.10.3 HUMAN CAPITAL AND SKILLED WORKFORCE
4.13.10.4 INFRASTRUCTURE AND CAPITAL INVESTMENT
4.13.10.5 POLICY IMPLICATIONS AND ECONOMIC PLANNING
4.13.10.6 IMPLICATIONS FOR THE ASIA PACIFIC CHD MARKET
5 TARIFFS & IMPACT ON THE MARKET
5.1 CURRENT TARIFF RATE(S) IN TOP-5 COUNTRY MARKETS
5.2 OUTLOOK: LOCAL PRODUCTION V/S IMPORT RELIANCE
5.3 VENDOR SELECTION CRITERIA DYNAMICS
5.4 IMPACT ON SUPPLY CHAIN
5.4.1 RAW MATERIAL PROCUREMENT
5.4.2 MANUFACTURING AND PRODUCTION
5.4.3 LOGISTICS AND DISTRIBUTION
5.4.4 PRICE PITCHING AND POSITION OF MARKET
5.5 INDUSTRY PARTICIPANTS: PROACTIVE MOVES
5.5.1 SUPPLY CHAIN OPTIMIZATION
5.5.2 JOINT VENTURE ESTABLISHMENTS
5.6 IMPACT ON PRICES
6 REGULATORY COMPLIANCE
6.1 REGULATORY AUTHORITIES
6.2 REGULATORY CLASSIFICATIONS
6.3 REGULATORY SUBMISSIONS
6.3.1 COMPONENTS OF REGULATORY SUBMISSIONS
6.3.2 SUBMISSION PATHWAYS IN KEY APAC MARKETS
6.3.3 EXPEDITED AND SPECIAL SUBMISSION ROUTES
6.3.4 ELECTRONIC SUBMISSIONS AND DIGITAL PLATFORMS
6.3.5 STRATEGIC CONSIDERATIONS FOR MANUFACTURERS
6.4 INTERNATIONAL HARMONIZATION
6.4.1 HARMONIZATION FRAMEWORKS AND GLOBAL REGULATORY FORUMS
6.4.2 REGIONAL CONVERGENCE INITIATIVES IN ASIA PACIFIC
6.4.3 REGULATORY RELIANCE AND MUTUAL RECOGNITION
6.4.4 BENEFITS OF HARMONIZATION TO THE MEDICAL DEVICE INDUSTRY
6.4.5 CHALLENGES AND ONGOING ADVANCES
6.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
6.6 REGULATORY CHALLENGES AND STRATEGIES
6.6.1 REGULATORY CHALLENGES
6.6.2 REGULATORY STRATEGIES FOR MARKET ACCESS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF CONGENITAL HEART DEFECTS IN NEWBORNS
7.1.2 TECHNOLOGICAL ADOPTION IN INTERVENTIONAL CARDIOLOGY AND DEVICE THERAPY
7.1.3 INCREASING AWARENESS AND EARLY DIAGNOSIS INITIATIVES
7.1.4 GROWTH IN HEALTHCARE INFRASTRUCTURE AND SPECIALIZED PAEDIATRIC CARDIAC UNITS
7.2 RESTRAINTS
7.2.1 HIGH COST FOR THE TREATMENT OF CONGENITAL HEART DISEASE
7.2.2 LIMITED ACCESS TO ADVANCED HEALTHCARE INFRASTRUCTURE
7.3 OPPORTUNITIES
7.3.1 INTEGRATION OF ARTIFICIAL INTELLIGENCE IN IMAGING INTERPRETATION AND RISK STRATIFICATION
7.3.2 SCALE-UP OF MINIMALLY INVASIVE TRANSCATHETER THERAPIES
7.3.3 INCREASED GOVERNMENT FUNDING AND PUBLIC-PRIVATE PARTNERSHIPS
7.4 CHALLENGES
7.4.1 SHORTAGE OF SKILLED PEDIATRIC CARDIOLOGISTS
7.4.2 REGULATORY HETEROGENEITY ACROSS ASIA-PACIFIC MARKETS
8 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSANDS)
8.1 OVERVIEW
8.2 TREATMENT
8.3 DIAGNOSTIC
8.4 ASIA-PACIFIC TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.4.1 INTERVENTIONAL DEVICES
8.4.2 SUPPORTIVE DEVICES
8.4.3 SURGICAL DEVICES
8.4.4 MEDICATION
8.4.5 OTHERS
8.5 ASIA-PACIFIC INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.5.1 SEPTAL OCCLUDERS
8.5.2 DELIVERY SYSTEMS
8.5.3 BALLOON CATHETERS
8.5.4 STENTS
8.6 ASIA-PACIFIC SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.6.1 ASD (ATRIAL SEPTAL DEFECT) OCCLUDERS
8.6.2 VSD (VENTRICULAR SEPTAL DEFECT) OCCLUDERS
8.7 ASIA-PACIFIC STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.7.1 DRUG-ELUTING STENTS
8.7.2 BARE-METAL STENTS
8.8 ASIA-PACIFIC SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.8.1 MONITORING SYSTEMS
8.8.2 INFUSION PUMPS
8.9 ASIA-PACIFIC SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.9.1 PEDIATRIC HEART VALVES
8.9.2 PEDIATRIC VENTRICULAR ASSIST DEVICES
8.9.3 GRAFTS & PATCHES
8.9.4 PEDIATRIC PACEMAKERS
8.9.5 DEFIBRILLATORS
8.1 ASIA-PACIFIC PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.10.1 BIOPROSTHETIC VALVES
8.10.2 MECHANICAL VALVES
8.11 ASIA-PACIFIC MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.11.1 ACE INHIBITORS
8.11.2 DIURETICS
8.11.3 BETA BLOCKERS
8.11.4 ANTICOAGULANTS
8.11.5 PROSTAGLANDIN ANALOGS
8.11.6 OTHERS
8.12 ASIA-PACIFIC DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
8.12.1 CARDIAC CATHETERIZATION LAB EQUIPMENT
8.12.2 ECHOCARDIOGRAPHY SYSTEMS
8.12.3 MRI SYSTEMS
8.12.4 X-RAY DEVICES
8.12.5 CT SCAN SYSTEMS
8.12.6 ELECTROCARDIOGRAPHY (ECG) DEVICES
8.13 ASIA-PACIFIC CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.13.1 ANGIOGRAPHY SYSTEMS
8.13.2 PRESSURE MONITORS
8.14 ASIA-PACIFIC ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.14.1 TRANSTHORACIC ECHOCARDIOGRAPHY
8.14.2 TRANSESOPHAGEAL ECHOCARDIOGRAPHY
8.14.3 FETAL ECHOCARDIOGRAPHY
8.15 ASIA-PACIFIC MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.15.1 CARDIAC MRI
8.15.2 WHOLE-BODY MRI
8.16 ASIA-PACIFIC CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.16.1 CARDIAC CT
8.16.2 ELECTRON BEAM CT
8.17 ASIA-PACIFIC ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.17.1 RESTING ECG
8.17.2 STRESS ECG
9 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE, 2018-2033 (USD THOUSANDS)
9.1 OVERVIEW
9.1.1 ACYANOTIC CONGENITAL HEART DISEASE
9.1.2 CYANOTIC CONGENITAL HEART DISEASE
9.1.3 COMPLEX CONGENITAL HEART DEFECTS
9.2 ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
9.2.1 VENTRICULAR SEPTAL DEFECT (VSD)
9.2.2 ATRIAL SEPTAL DEFECT (ASD)
9.2.3 PULMONARY STENOSIS
9.2.4 PATENT DUCTUS ARTERIOSUS (PDA)
9.2.5 AORTIC STENOSIS
9.3 ASIA-PACIFIC VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.3.1 MEMBRANOUS VSD
9.3.2 MUSCULAR VSD
9.4 ASIA-PACIFIC ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.4.1 OSTIUM SECUNDUM ASD
9.4.2 OSTIUM PRIMUM ASD
9.5 ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
9.5.1 TREATMENT
9.5.2 DIAGNOSTIC
9.6 ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
9.6.1 TRANSPOSITION OF GREAT ARTERIES
9.6.2 TETRALOGY OF FALLOT
9.6.3 HYPOPLASTIC LEFT HEART SYNDROME
9.6.4 TRICUSPID ATRESIA
9.7 ASIA-PACIFIC TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
9.7.1 PULMONARY ATRESIA
9.7.2 OVERRIDING AORTA
9.7.3 RIGHT VENTRICULAR HYPERTROPHY
9.8 ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
9.8.1 TREATMENT
9.8.2 DIAGNOSTIC
9.9 ASIA-PACIFIC COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
9.9.1 TREATMENT
9.9.2 DIAGNOSTIC
10 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSANDS)
10.1 OVERVIEW
10.1.1 ADULTS WITH CONGENITAL HEART DISEASE
10.1.2 NEONATES AND INFANTS (0–1 YEARS)
10.1.3 CHILDREN (1–12 YEARS)
10.1.4 ADOLESCENTS (13–18 YEARS)
11 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET, BY END USER, 2018-2033 (USD THOUSANDS)
11.1 OVERVIEW
11.2 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
11.2.1 HOSPITALS
11.2.2 PEDIATRIC CARDIAC CENTERS
11.2.3 SPECIALTY CLINICS
11.2.4 DIAGNOSTIC LABORATORIES
11.2.5 RESEARCH & ACADEMIC INSTITUTES
11.2.6 HOMECARE SETTINGS
11.2.7 OTHER END USERS
11.3 ASIA-PACIFIC HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
11.3.1 PUBLIC
11.3.2 PRIVATE
12 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSANDS)
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 WHOLESALE DISTRIBUTORS
12.4 RETAIL SALES
12.5 ONLINE SALES
12.6 OTHERS
13 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET BY COUNTRIES
13.1 ASIA PACIFIC
13.1.1 CHINA
13.1.2 JAPAN
13.1.3 INDIA
13.1.4 SOUTH KOREA
13.1.5 AUSTRALIA
13.1.6 INDONESIA
13.1.7 THAILAND
13.1.8 TAIWAN
13.1.9 VIETNAM
13.1.10 MALAYSIA
13.1.11 SINGAPORE
13.1.12 PHILIPPINES
13.1.13 NEW ZEALAND
13.1.14 REST OF ASIA-PACIFIC
14 ASIA PACIFIC CONGENITAL HEAR DISEASE MARKET
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
15 SWOT ANALYSIS
16 MEDICAL DEVICE COMPANY PROFILE
16.1 MEDTRONIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 PRODUCT PORTFOLIO
16.1.4 RECENT DEVELOPMENT
16.2 EDWARDS LIFESCIENCES CORPORATION
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENT
16.3 TRIVITRON HEALTHCARE
16.3.1 COMPANY SNAPSHOT
16.3.2 PRODUCT PORTFOLIO
16.3.3 RECENT DEVELOPMENT
16.4 ARTIVION, INC.
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 ABBOTT
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 BOSTON SCIENTIFIC CORPORATION
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 TERUMO CORPORATION
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 SHANGHAI MICROPORT SCIENTIFIC CORPORATION
16.8.1 COMPANY SNAPSHOT
16.8.2 REVENUE ANALYSIS
16.8.3 PRODUCT PORTFOLIO
16.8.4 RECENT DEVELOPMENT
16.9 LIFETECH SCIENTIFIC
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 PRODUCT PORTFOLIO
16.9.4 RECENT DEVELOPMENT
16.1 LEPU MEDICAL TECHNOLOGY
16.10.1 COMPANY SNAPSHOT
16.10.2 REVENUE ANALYSIS
16.10.3 PRODUCT PORTFOLIO
16.10.4 RECENT DEVELOPMENT
16.11 W. L. GORE & ASSOCIATES INC.
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 MERIL
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LIVANOVA PLC
16.13.1 COMPANY SNAPSHOT
16.13.2 REVENUE ANALYSIS
16.13.3 PRODUCT/SERVICE PORTFOLIO
16.13.4 RECENT DEVELOPMENT
16.14 B. BRAUN SE
16.14.1 COMPANY SNAPSHOT
16.14.2 PRODUCT/SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 SIEMENS HEALTHINEERS AG
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT/SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENT
16.16 KONINKLIJKE PHILIPS N.V.
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 PRODUCT/SERVICE PORTFOLIO
16.16.4 RECENT DEVELOPMENT
16.17 GE HEALTHCARE
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT/SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 GETINGE AB
16.18.1 COMPANY SNAPSHOT
16.18.2 REVENUE ANALYSIS
16.18.3 PRODUCT PORTFOLIO
16.18.4 RECENT DEVELOPMENT
16.19 INTEGER HOLDINGS CORPORATION (PARENT COMPANY OF OSCOR INC.)
16.19.1 COMPANY SNAPSHOT
16.19.2 REVENUE ANALYSIS
16.19.3 PRODUCT PORTFOLIO
16.19.4 RECENT DEVELOPMENT
16.2 NARANG MEDICAL LIMITED
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
17 PHARMA COMPANY PROFILE
17.1 NOVARTIS AG
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 PRODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 PFIZER INC.
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 ASTRAZENECA PLC
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 SUN PHARMACEUTICAL INDUSTRIES LTD.
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENT
17.5 BRISTOL-MYERS SQUIBB (BMS)
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 PRODUCT PORTFOLIO
17.5.4 RECENT DEVELOPMENT
17.6 ADVACARE PHARMA
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 2 ASIA-PACIFIC TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 3 ASIA-PACIFIC INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 4 ASIA-PACIFIC SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 5 ASIA-PACIFIC STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 6 ASIA-PACIFIC SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 7 ASIA-PACIFIC SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 8 ASIA-PACIFIC PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 9 ASIA-PACIFIC MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 10 ASIA-PACIFIC DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 11 ASIA-PACIFIC CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 12 ASIA-PACIFIC ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 13 ASIA-PACIFIC MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 14 ASIA-PACIFIC CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 15 ASIA-PACIFIC ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 16 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 17 ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 18 ASIA-PACIFIC VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 19 ASIA-PACIFIC ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 21 ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 22 ASIA-PACIFIC TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 23 ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 24 ASIA-PACIFIC COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 25 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 26 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 27 ASIA-PACIFIC HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 28 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 29 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 30 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 31 ASIA-PACIFIC TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 32 ASIA-PACIFIC INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 33 ASIA-PACIFIC SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 34 ASIA-PACIFIC STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 35 ASIA-PACIFIC SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 36 ASIA-PACIFIC SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 37 ASIA-PACIFIC PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 38 ASIA-PACIFIC MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 39 ASIA-PACIFIC DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 40 ASIA-PACIFIC CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 41 ASIA-PACIFIC ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 42 ASIA-PACIFIC MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 ASIA-PACIFIC CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 44 ASIA-PACIFIC ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 45 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 46 ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 47 ASIA-PACIFIC VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 48 ASIA-PACIFIC ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 49 ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 50 ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 51 ASIA-PACIFIC TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 52 ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 53 ASIA-PACIFIC COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 54 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 55 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 56 ASIA-PACIFIC HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 57 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 58 CHINA CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 59 CHINA TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 60 CHINA INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 61 CHINA SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 62 CHINA STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 63 CHINA SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 64 CHINA SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 65 CHINA PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 66 CHINA MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 67 CHINA DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 68 CHINA CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 69 CHINA ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 70 CHINA MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 71 CHINA CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 72 CHINA ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 73 CHINA CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 74 CHINA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 75 CHINA VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 76 CHINA ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 77 CHINA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 78 CHINA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 79 CHINA TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 80 CHINA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 81 CHINA COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 82 CHINA CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 83 CHINA CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 84 CHINA HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 85 CHINA CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 86 JAPAN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 87 JAPAN TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 88 JAPAN INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 89 JAPAN SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 90 JAPAN STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 91 JAPAN SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 JAPAN SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 JAPAN PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 94 JAPAN MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 JAPAN DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 96 JAPAN CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 97 JAPAN ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 98 JAPAN MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 99 JAPAN CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 JAPAN ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 JAPAN CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 102 JAPAN ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 103 JAPAN VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 JAPAN ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 105 JAPAN ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 106 JAPAN CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 107 JAPAN TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 108 JAPAN CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 109 JAPAN COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 110 JAPAN CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 111 JAPAN CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 112 JAPAN HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 113 JAPAN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 114 INDIA CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 115 INDIA TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 116 INDIA INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 117 INDIA SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 118 INDIA STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 119 INDIA SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 120 INDIA SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 INDIA PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 122 INDIA MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 123 INDIA DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 124 INDIA CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 125 INDIA ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 126 INDIA MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 127 INDIA CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 INDIA ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 129 INDIA CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 130 INDIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 131 INDIA VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 132 INDIA ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 133 INDIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 134 INDIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 135 INDIA TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 INDIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 137 INDIA COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 138 INDIA CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 139 INDIA CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 140 INDIA HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 141 INDIA CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 SOUTH KOREA CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 143 SOUTH KOREA TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 144 SOUTH KOREA INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 145 SOUTH KOREA SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 SOUTH KOREA STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 147 SOUTH KOREA SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 148 SOUTH KOREA SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 149 SOUTH KOREA PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 150 SOUTH KOREA MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 151 SOUTH KOREA DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 152 SOUTH KOREA CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 153 SOUTH KOREA ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 154 SOUTH KOREA MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 155 SOUTH KOREA CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 SOUTH KOREA ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 157 SOUTH KOREA CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 158 SOUTH KOREA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 159 SOUTH KOREA VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 160 SOUTH KOREA ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 161 SOUTH KOREA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 162 SOUTH KOREA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 163 SOUTH KOREA TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 SOUTH KOREA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 165 SOUTH KOREA COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 166 SOUTH KOREA CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 167 SOUTH KOREA CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 168 SOUTH KOREA HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 SOUTH KOREA CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 AUSTRALIA CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 171 AUSTRALIA TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 172 AUSTRALIA INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 173 AUSTRALIA SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 AUSTRALIA STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 175 AUSTRALIA SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 176 AUSTRALIA SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 AUSTRALIA PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 178 AUSTRALIA MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 179 AUSTRALIA DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 180 AUSTRALIA CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 AUSTRALIA ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 182 AUSTRALIA MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 183 AUSTRALIA CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 184 AUSTRALIA ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 185 AUSTRALIA CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 186 AUSTRALIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 187 AUSTRALIA VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 188 AUSTRALIA ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 189 AUSTRALIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 190 AUSTRALIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 191 AUSTRALIA TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 192 AUSTRALIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 193 AUSTRALIA COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 194 AUSTRALIA CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 195 AUSTRALIA CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 196 AUSTRALIA HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 AUSTRALIA CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 INDONESIA CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 199 INDONESIA TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 INDONESIA INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 201 INDONESIA SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 202 INDONESIA STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 203 INDONESIA SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 204 INDONESIA SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 INDONESIA PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 INDONESIA MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 207 INDONESIA DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 208 INDONESIA CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 209 INDONESIA ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 210 INDONESIA MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 211 INDONESIA CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 INDONESIA ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 213 INDONESIA CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 214 INDONESIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 215 INDONESIA VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 INDONESIA ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 217 INDONESIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 218 INDONESIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 219 INDONESIA TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 220 INDONESIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 221 INDONESIA COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 222 INDONESIA CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 223 INDONESIA CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 224 INDONESIA HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 225 INDONESIA CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 226 THAILAND CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 227 THAILAND TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 228 THAILAND INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 229 THAILAND SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 230 THAILAND STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 231 THAILAND SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 232 THAILAND SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 THAILAND PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 234 THAILAND MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 235 THAILAND DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 236 THAILAND CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 237 THAILAND ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 238 THAILAND MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 239 THAILAND CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 240 THAILAND ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 241 THAILAND CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 242 THAILAND ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 243 THAILAND VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 244 THAILAND ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 245 THAILAND ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 246 THAILAND CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 247 THAILAND TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 248 THAILAND CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 249 THAILAND COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 250 THAILAND CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 251 THAILAND CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 252 THAILAND HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 253 THAILAND CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 254 TAIWAN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 255 TAIWAN TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 256 TAIWAN INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 257 TAIWAN SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 258 TAIWAN STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 259 TAIWAN SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 260 TAIWAN SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 261 TAIWAN PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 262 TAIWAN MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 263 TAIWAN DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 264 TAIWAN CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 265 TAIWAN ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 266 TAIWAN MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 267 TAIWAN CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 TAIWAN ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 269 TAIWAN CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 270 TAIWAN ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 271 TAIWAN VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 272 TAIWAN ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 273 TAIWAN ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 274 TAIWAN CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 275 TAIWAN TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 276 TAIWAN CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 277 TAIWAN COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 278 TAIWAN CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 279 TAIWAN CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 280 TAIWAN HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 281 TAIWAN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 282 VIETNAM CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 283 VIETNAM TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 284 VIETNAM INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 285 VIETNAM SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 286 VIETNAM STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 287 VIETNAM SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 288 VIETNAM SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 289 VIETNAM PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 290 VIETNAM MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 291 VIETNAM DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 292 VIETNAM CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 293 VIETNAM ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 294 VIETNAM MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 295 VIETNAM CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 296 VIETNAM ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 297 VIETNAM CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 298 VIETNAM ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 299 VIETNAM VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 300 VIETNAM ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 301 VIETNAM ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 302 VIETNAM CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 303 VIETNAM TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 304 VIETNAM CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 305 VIETNAM COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 306 VIETNAM CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 307 VIETNAM CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 308 VIETNAM HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 VIETNAM CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 310 MALAYSIA CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 311 MALAYSIA TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 312 MALAYSIA INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 313 MALAYSIA SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 314 MALAYSIA STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 315 MALAYSIA SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 316 MALAYSIA SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 317 MALAYSIA PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 318 MALAYSIA MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 319 MALAYSIA DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 320 MALAYSIA CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 321 MALAYSIA ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 322 MALAYSIA MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 323 MALAYSIA CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 324 MALAYSIA ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 325 MALAYSIA CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 326 MALAYSIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 327 MALAYSIA VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 328 MALAYSIA ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 329 MALAYSIA ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 330 MALAYSIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 331 MALAYSIA TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 332 MALAYSIA CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 333 MALAYSIA COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 334 MALAYSIA CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 335 MALAYSIA CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 336 MALAYSIA HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 337 MALAYSIA CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 338 SINGAPORE CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 339 SINGAPORE TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 340 SINGAPORE INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 341 SINGAPORE SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 342 SINGAPORE STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 343 SINGAPORE SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 344 SINGAPORE SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 345 SINGAPORE PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 346 SINGAPORE MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 347 SINGAPORE DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 348 SINGAPORE CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 349 SINGAPORE ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 350 SINGAPORE MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 351 SINGAPORE CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 352 SINGAPORE ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 353 SINGAPORE CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 354 SINGAPORE ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 355 SINGAPORE VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 356 SINGAPORE ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 357 SINGAPORE ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 358 SINGAPORE CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 359 SINGAPORE TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 360 SINGAPORE CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 361 SINGAPORE COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 362 SINGAPORE CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 363 SINGAPORE CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 364 SINGAPORE HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 365 SINGAPORE CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 366 PHILIPPINES CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 367 PHILIPPINES TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 368 PHILIPPINES INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 369 PHILIPPINES SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 370 PHILIPPINES STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 371 PHILIPPINES SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 372 PHILIPPINES SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 373 PHILIPPINES PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 374 PHILIPPINES MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 375 PHILIPPINES DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 376 PHILIPPINES CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 377 PHILIPPINES ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 378 PHILIPPINES MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 PHILIPPINES CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 380 PHILIPPINES ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 381 PHILIPPINES CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 382 PHILIPPINES ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 383 PHILIPPINES VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 384 PHILIPPINES ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 385 PHILIPPINES ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 386 PHILIPPINES CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 387 PHILIPPINES TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 388 PHILIPPINES CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 389 PHILIPPINES COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 390 PHILIPPINES CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 391 PHILIPPINES CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 392 PHILIPPINES HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 393 PHILIPPINES CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 394 NEW ZEALAND CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 395 NEW ZEALAND TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 396 NEW ZEALAND INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 397 NEW ZEALAND SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 398 NEW ZEALAND STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 399 NEW ZEALAND SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 400 NEW ZEALAND SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 401 NEW ZEALAND PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 402 NEW ZEALAND MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 403 NEW ZEALAND DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 404 NEW ZEALAND CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 405 NEW ZEALAND ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 406 NEW ZEALAND MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 407 NEW ZEALAND CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 408 NEW ZEALAND ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 409 NEW ZEALAND CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 410 NEW ZEALAND ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 411 NEW ZEALAND VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 412 NEW ZEALAND ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 413 NEW ZEALAND ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 414 NEW ZEALAND CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 415 NEW ZEALAND TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 416 NEW ZEALAND CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 417 NEW ZEALAND COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 418 NEW ZEALAND CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 419 NEW ZEALAND CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 420 NEW ZEALAND HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 421 NEW ZEALAND CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 422 REST OF ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2018-2033 (USD THOUSAND)
TABLE 423 REST OF ASIA-PACIFIC TREATMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 424 REST OF ASIA-PACIFIC INTERVENTIONAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 425 REST OF ASIA-PACIFIC SEPTAL OCCLUDERS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 426 REST OF ASIA-PACIFIC STENTS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 427 REST OF ASIA-PACIFIC SUPPORTIVE DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 428 REST OF ASIA-PACIFIC SURGICAL DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 429 REST OF ASIA-PACIFIC PEDIATRIC HEART VALVES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 430 REST OF ASIA-PACIFIC MEDICATION IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 431 REST OF ASIA-PACIFIC DIAGNOSTIC IN CONGENITAL HEART DISEASE MARKET, BY DEVICE TYPE, 2018-2033 (USD THOUSAND)
TABLE 432 REST OF ASIA-PACIFIC CARDIAC CATHETERIZATION LAB EQUIPMENT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 433 REST OF ASIA-PACIFIC ECHOCARDIOGRAPHY SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 434 REST OF ASIA-PACIFIC MRI SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 435 REST OF ASIA-PACIFIC CT SCAN SYSTEMS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 436 REST OF ASIA-PACIFIC ELECTROCARDIOGRAPHY (ECG) DEVICES IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 437 REST OF ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 438 REST OF ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 439 REST OF ASIA-PACIFIC VENTRICULAR SEPTAL DEFECT (VSD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 440 REST OF ASIA-PACIFIC ATRIAL SEPTAL DEFECT (ASD) IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 441 REST OF ASIA-PACIFIC ACYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 442 REST OF ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY TYPES, 2018-2033 (USD THOUSAND)
TABLE 443 REST OF ASIA-PACIFIC TETRALOGY OF FALLOT IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 444 REST OF ASIA-PACIFIC CYANOTIC CONGENITAL HEART DISEASE IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 445 REST OF ASIA-PACIFIC COMPLEX CONGENITAL HEART DEFECTS IN CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE , 2018-2033 (USD THOUSAND)
TABLE 446 REST OF ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2018-2033 (USD THOUSAND)
TABLE 447 REST OF ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY END USER , 2018-2033 (USD THOUSAND)
TABLE 448 REST OF ASIA-PACIFIC HOSPITALS IN CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 449 REST OF ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
그림 목록
FIGURE 1 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: COUNTRYWISE MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: MULTIVARIATE MODELLING
FIGURE 8 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: MARKET END-USER COVERAGE GRID
FIGURE 11 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: SEGMENTATION
FIGURE 12 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: EXECUTIVE SUMMARY
FIGURE 13 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: STRATEGIC DECISIONS
FIGURE 14 TWO SEGMENTS COMPRISE THE DOMINICAN REPUBLIC ENDOSCOPIC HEMOSTASIS MARKET, BY PRODUCT TYPE
FIGURE 15 RISING PREVALENCE OF CONGENITAL HEART DEFECTS IN NEWBORNS EXPECTED TO DRIVE THE GROWTH OF THE ASIA PACIFIC CONGENITAL HEART DISEASE MARKET FROM 2026 TO 2033
FIGURE 16 THE TYPE 2 ENDOSCOPIC HEMOSTASIS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC CONGENITAL HEART DISEASE MARKET IN 2026 & 2033
FIGURE 17 DROC ANALYSIS
FIGURE 18 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY PRODUCT TYPE, 2025
FIGURE 19 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY PRODUCT TYPE, 2026-2033 (USD THOUSAND)
FIGURE 20 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY PRODUCT TYPE, CAGR (2026-2033)
FIGURE 21 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISEASE TYPE, 2025
FIGURE 23 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY DISEASE TYPE, 2026-2033 (USD THOUSAND)
FIGURE 24 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY DISEASE TYPE, CAGR (2026-2033)
FIGURE 25 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY AGE GROUP, 2025
FIGURE 27 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY AGE GROUP, 2026-2033 (USD THOUSAND)
FIGURE 28 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY AGE GROUP, CAGR (2026-2033)
FIGURE 29 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY END USER, 2025
FIGURE 31 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY END USER, 2026-2033 (USD THOUSAND)
FIGURE 32 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY END USER, CAGR (2026-2033)
FIGURE 33 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET, BY DISTRIBUTION CHANNEL, 2025
FIGURE 35 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY DISTRIBUTION CHANNEL, 2026-2033 (USD THOUSAND)
FIGURE 36 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026-2033)
FIGURE 37 ASIA-PACIFIC CONGENITAL HEART DISEASE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET SNAPSHOTS
FIGURE 39 ASIA PACIFIC CONGENITAL HEART DISEASE MARKET: COMPANY SHARE 2025 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
